acth (4-9) has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duckers, HJ; Gispen, WH; Muller, HJ; Nicolay, K; Verhaagen, J | 1 |
Coenen, AM; Duckers, HJ; Gispen, WH; Lopes da Silva, FH; van Dokkum, RP; van Luijtelaar, EL; Verhaagen, J | 1 |
2 other study(ies) available for acth (4-9) and Disease Exacerbation
Article | Year |
---|---|
Longitudinal in vivo magnetic resonance imaging studies in experimental allergic encephalomyelitis: effect of a neurotrophic treatment on cortical lesion development.
Topics: Adrenocorticotropic Hormone; Animals; Cerebral Cortex; Demyelinating Diseases; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Evoked Potentials, Motor; Evoked Potentials, Somatosensory; Female; Longitudinal Studies; Magnetic Resonance Imaging; Peptide Fragments; Rats; Rats, Inbred Lew | 1997 |
Neurotrophic ACTH4-9 analogue therapy normalizes electroencephalographic alterations in chronic experimental allergic encephalomyelitis.
Topics: Adrenocorticotropic Hormone; Animals; Awareness; Brain; Chronic Disease; Disease Progression; Electroencephalography; Encephalomyelitis, Autoimmune, Experimental; Evoked Potentials, Visual; Freund's Adjuvant; Male; Peptide Fragments; Photic Stimulation; Rats; Rats, Inbred Lew; Weight Loss | 1998 |